Tuesday, June 30, 2009
FDA Requests Public Comments By August 25, 2009
In response to industry requests for better insight into how FDA evaluates promotional materials for prescription drugs and medical devices for compliance with statutory and regulatory requirements, FDA issued a Draft Guidance document on May 26, 2009, titled "Presenting Risk Information in Prescription...
